The “Drug-Seeking” Label: When a Patient in Pain Becomes a Suspect

A patient is hospitalized in severe pain.

They know which medication has worked during previous hospitalizations. They know the dose they normally take. They may even know that one medication causes a reaction while another provides relief.

Then they ask for it.

Sometimes that knowledge helps the healthcare team. Sometimes it produces a very different reaction:

Is this patient drug-seeking?

Few labels can change a pain patient’s relationship with healthcare as quickly.

What Does “Drug-Seeking” Actually Mean?

Clinicians have legitimate reasons to be cautious with controlled substances. Opioids can cause sedation, respiratory depression, physical dependence, and overdose. Opioid-use disorder is a serious medical condition, and the United States has experienced an enormous overdose crisis.

According to the CDC, drug overdose deaths have involved hundreds of thousands of Americans over the past two decades, with illicitly manufactured fentanyl becoming a major driver of opioid-related mortality.

Safe prescribing matters.

But identifying medication risk is different from assuming that a person reporting pain is manipulating the healthcare system.

Patients with chronic pain may know medications unusually well simply because they have spent years taking them. Patients who receive opioids regularly may also develop tolerance, meaning a dose that would strongly affect an opioid-naïve patient may have a different effect in them.

Physical dependence can also occur during legitimate long-term treatment and is not, by itself, the same thing as addiction or opioid-use disorder.

When the Label Follows the Patient

Hospital documentation is powerful.

Once terms implying “drug-seeking,” “medication-seeking,” “noncompliant,” or similar judgments appear in a chart, they may influence how subsequent clinicians interpret the patient.

The concern is not that clinicians should ignore suspicious or dangerous medication patterns. They shouldn’t.

The problem arises when the label becomes a substitute for assessment.

A patient with opioid-use disorder can develop appendicitis.

A patient receiving methadone or buprenorphine can break a bone.

A person with a history of overdose can undergo major surgery.

And someone who previously misused medication can still experience severe, legitimate pain.

These realities can exist simultaneously.

Substance-Use Disorder Does Not Eliminate Pain

This is one of the most important principles in compassionate pain care.

A history of addiction changes some treatment considerations, but it doesn’t eliminate the nervous system’s ability to experience pain.

Managing acute pain in people with opioid tolerance or opioid-use disorder can actually be more complicated than managing pain in an opioid-naïve patient. Depending on the circumstances, clinicians may need to consider baseline medications, tolerance, withdrawal prevention, non-opioid therapies, regional anesthesia, and carefully monitored additional analgesia.

For patients taking medications such as buprenorphine, contemporary guidance increasingly emphasizes thoughtful management rather than automatically stopping treatment.

These situations may benefit from collaboration among the hospital team, pain specialists, pharmacists, anesthesia professionals, and addiction-medicine clinicians.

The Opioid Crisis Changed Pain Care

The overdose epidemic forced medicine to confront years of unsafe opioid prescribing.

That correction was necessary.

But healthcare also has to recognize the danger of swinging from indiscriminate prescribing to indiscriminate suspicion.

The CDC’s 2022 opioid prescribing guideline specifically cautioned against inflexible application of opioid policies and emphasized individualized, patient-centered decision-making. The guideline primarily addresses outpatient pain care, but its larger lesson is important: clinical guidance should support judgment, not replace it.

Hospitals likewise need to balance two obligations—reducing medication-related harm and relieving suffering.

A Better Conversation

Instead of beginning with “Is this patient seeking drugs?” a more clinically useful set of questions might be:

What is causing the pain?

What treatments has the patient already received?

What normally works or doesn’t work?

Does the patient have opioid tolerance?

Is there evidence of withdrawal?

Are there medication interactions or safety concerns?

Could non-opioid or regional treatments help?

Does addiction medicine or pain management need to be involved?

Those questions don’t guarantee that a patient will receive the medication they request.

They do something more important: they return the conversation to medicine.

A patient’s history should inform care. It shouldn’t erase the patient’s credibility.

Research starting points

• Centers for Disease Control and Prevention. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR.
• Substance Abuse and Mental Health Services Administration (SAMHSA), resources on medications for opioid-use disorder.
• American Society of Addiction Medicine (ASAM), clinical guidance concerning opioid-use disorder.